FDA urged to revise contraceptive labels over blood clot risks
December 09, 2011
A panel that advises the Food and Drug Administration (FDA) is calling upon the agency to revise the labels of Yaz and Yasmin, two popular forms of the birth control pill.
The FDA, which has linked 50 deaths to the drugs, has found that “women taking Yasmin were about twice as likely to develop venous or arterial thrombotic events (VTEs and ATEs) than women on older birth control,” according to Reuters. Bayer, the pills’ maker, is facing 10,000 lawsuits alleging harm caused by the drugs.
In a close 15-11 vote, the panel stated that the benefits of the drugs nonetheless outweigh the risks.
For all current news, visit our News home page.
Further information:
- FDA advisers: revise popular birth control labels (Reuters)
- Gynecologists Unfazed by Birth Control Clot Concerns (Bloomberg)
All comments are moderated. To lighten our editing burden, only current donors are allowed to Sound Off. If you are a current donor, log in to see the comment form; otherwise please support our work, and Sound Off!
-
Posted by: hartwood01 -
Dec. 13, 2011 4:43 PM ET USA
Many physicians worship at the feet of Pharmacy. You won't find them reluctant to prescribe,especially the latest and greatest,which is introduced with minimal testing to rush to market.
-
Posted by: rpp -
Dec. 10, 2011 7:48 PM ET USA
Any other drug would have been pulled form the market as a consequence of so many deaths.
